Brave-Examination-70
Brave-Examination-70 t1_jegbq46 wrote
Reply to TIL that The National Library of Medicine has a Pillbox dataset made up of 8,693 photographs of pills, with an accompanying database of drug information. It was built to help with the identification of unknown pills. by jonkeegan
Kind of strange considering most medications come in a variety of colors, and forms, sometimes with letters/numbers, sometimes without. Might be useful to have a standardized color and labeling system.
Brave-Examination-70 t1_j1iwcaz wrote
Reply to comment by qtx in The $52 billion plan to save New York’s low-lying areas from sea level rise and storm surges by ChiggaOG
The Dutch have mostly stopped building seawalls and are instead restoring the natural barriers that would prevent this like wetlands and sandbars.
Brave-Examination-70 t1_j1iw23q wrote
Reply to comment by asdaaaaaaaa in The $52 billion plan to save New York’s low-lying areas from sea level rise and storm surges by ChiggaOG
Cities are vastly more efficient than suburbs.
Brave-Examination-70 t1_j1ivzr9 wrote
Reply to comment by Agent_Angelo_Pappas in The $52 billion plan to save New York’s low-lying areas from sea level rise and storm surges by ChiggaOG
They'd be better off restoring the wetlands, sandbars, and other natural elements that used to prevent this from happening. Cheaper and more effective.
Brave-Examination-70 t1_j1ivtkw wrote
Reply to The $52 billion plan to save New York’s low-lying areas from sea level rise and storm surges by ChiggaOG
Or you could stop building in a floodplain and restore the wetlands and sandbars that used to prevent this from happening...
Brave-Examination-70 t1_jeh0kj7 wrote
Reply to comment by ledow in TIL that The National Library of Medicine has a Pillbox dataset made up of 8,693 photographs of pills, with an accompanying database of drug information. It was built to help with the identification of unknown pills. by jonkeegan
For sure. One of those many things that seem obvious once you think about it, but won’t happen until someone comes along with the political or social capital to champion it and oppose a pharma industry that will fight against any minor expense or threat to their brand.